Small-cap pharma stock jumps over 10% despite dip in key indices of Indian stock market
Balaxi Pharmaceuticals' shares rose 10% to ₹39.5 despite broader market declines, but remain down 11.50% in November. The stock has faced selling pressure since May 2024, losing 47.42% this year and 17% last year, significantly impacting retail investors.
Balaxi Pharmaceuticals' shares rose 10% to ₹39.5 despite broader market declines, but remain down 11.50% in November. The stock has faced selling pressure since May 2024, losing 47.42% this year and 17% last year, significantly impacting retail investors.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
